Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2025-12-25 @ 1:12 AM
NCT ID:
NCT04143893
Eligibility Criteria:
Inclusion Criteria:
* 19 years old or older
* Cardiogenic shock is defined as the presence of the following:
1. Systolic blood pressure is less than 90mmHg for more than 30 minutes despite the fluid therapy, or the use of pressure boosting agents to maintain the systolic blood pressure more than 90 mmHg.
2. Peripheral hypoperfusion (cold skin, urine less than 30 cc per hour, impaired consciousness, lactate ≥2.0 mmol/l) or a person with pulmonary edema.
* Causes of cardiogenic shock include ischemic (acute myocardial infarction or ischemic cardiomyopathy, shock during cardiac intervention), myocardial (end-stage heart failure, myocarditis), post-cardiotomy shock, cardiac tamponade, or pulmonary thromboembolism.
* Those voluntarily consenting to the medical records and the data necessary for the study during the entire study period.
Exclusion Criteria:
* Other causes except for cardiogenic shock: septic shock, cardiac arrest by serious ventricular arrhythmia not related to the myocardial ischemia or heart failure
* Shock with unwitnessed cardiac arrest outside the hospital
* Severe non-cardiac morbidity with expected survival less than 6 months (malignancy, respiratory failure)
* Those who refused active treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT04143893
Study Brief:
Protocol Section:
NCT04143893